Abnormal differentiation of erythroid precursors in p45 NF-E2 -/- mice

Experimental Hematology

Volumn 40, Issue 5, 2012, Pages 393-400

  Gasiorek, Jadwiga J ^a,b   Nouhi, Zaynab ^a,b   Blank, Volker ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NF E2 P45 SUBUNIT;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SPLEEN; WILD TYPE;

ANIMALS; ANTIGENS, CD; BLOOD GROUP ANTIGENS; BONE MARROW; ERYTHROBLASTS; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; G1 PHASE; GATA1 TRANSCRIPTION FACTOR; MICE; MICE, KNOCKOUT; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; RECEPTORS, TRANSFERRIN; SPLEEN;

ANIMALIA; MUS;

EID: 84859729021     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.007     Document Type: Article

References (42)

1. Gregory C., Eaves A. Three stages of erythropoietic progenitor stage differentiation distinguished by a number of physical and biologic properties. Blood 1978, 51:527-537.
2. Rifkind R., Chui D., Epler H. An ultrastructural study of early morphogenetic events during the establishment of fetal hepatic erythropoiesis. J Cell Biol 1969, 40:343-365.
3. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., Orkin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993, 362:722-728.
4. Andrews N.C., Kotkow K.J., Ney P.A., Erdjument-Bromage H., Tempst P., Orkin S.H. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci U S A 1993, 90:11488-11492.
5. Mignotte V., Wall L., deBoer E., Grosveld F., Romeo P.H. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res 1989, 17:37-54.
6. Hu M., Krause D., Greaves M., et al. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 1997, 11:774-785.
7. Blank V., Knoll J.H., Andrews N.C. Molecular characterization and localization of the human MAFG gene. Genomics 1997, 44:147-149.
8. Blank V. Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J Mol Biol 2008, 376:913-925.
9. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., Engel J.D. The world according to Maf. Nucleic Acids Res 1997, 25:2953-2959.
10. Lu S.J., Rowan S., Bani M.R., Ben-David Y. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc Natl Acad Sci U S A 1994, 91:8398-8402.
11. Kotkow K.J., Orkin S.H. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol Cell Biol 1995, 15:4640-4647.
12. Blank V., Kim M.J., Andrews N.C. Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression. Blood 1997, 89:3925-3935.
13. Moore A., Boudia M.M., Lehalle D., Massrieh W., Derjuga A., Blank V. Regulation of globin gene transcription by heme in erythroleukemia cells: analysis of putative heme regulatory motifs in the p45 NF-E2 transcription factor. Antioxid Redox Signal 2006, 8:68-75.
14. Ney P.A., Sorrentino B.P., Lowrey C.H., Nienhuis A.W. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res 1990, 18:6011-6017.
15. Forsberg E.C., Downs K.M., Bresnick E.H. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. Blood 2000, 96:334-339.
16. Armstrong J.A., Emerson B.M. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro. Mol Cell Biol 1996, 16:5634-5644.
17. Boyes J., Felsenfeld G. Tissue-specific factors additively increase the probability of the all- or-none formation of a hypersensitive site. EMBO J 1996, 15:2496-2507.
18. Gong Q.H., McDowell J.C., Dean A. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region. Mol Cell Biol 1996, 16:6055-6064.
19. Johnson K.D., Christensen H.M., Zhao B., Bresnick E.H. Distinct mechanisms control RNA polymerase II recruitment to a tissue- specific locus control region and a downstream promoter. Mol Cell 2001, 8:465-471.
20. Sawado T., Igarashi K., Groudine M. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta -globin LCR and gene promoter. Proc Natl Acad Sci U S A 2001, 98:10226-10231.
21. Stamatoyannopoulos J.A., Goodwin A., Joyce T., Lowrey C.H. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region. EMBO J 1995, 14:106-116.
22. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 1995, 81:695-704.
23. Lecine P., Villeval J.L., Vyas P., Swencki B., Xu Y., Shivdasani R.A. Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes. Blood 1998, 92:1608-1616.
24. Shivdasani R.A., Orkin S.H. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc Natl Acad Sci U S A 1995, 92:8690-8694.
25. Levin J., Peng J.P., Baker G.R., et al. Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood 1999, 94:3037-3047.
26. Chan J.Y. Reduced oxidative-stress response in red blood cells from p45NFE2-deficient mice. Blood 2001, 97:2151-2158.
27. Kacena M.A., Gundberg C.M., Nelson T., Horowitz M.C. Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype. Bone 2005, 36:215-223.
28. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A 1996, 93:12355-12358.
29. Suzuki N., Suwabe N., Ohneda O., et al. Identification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levels. Blood 2003, 102:3575-3583.
30. Whyatt D., Lindeboom F., Karis A., et al. An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells. Nature 2000, 406:519-524.
31. Zon L.I., Youssoufian H., Mather C., Lodish H.F., Orkin S.H. Activation of the erythropoeitin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci U S A 1991, 88:10638-10641.
32. Evans T., Reitman M., Felsenfeld G. An erythroid-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci U S A 1988, 85:5976-5980.
33. Wall L., deBoer E., Grosveld F. The human beta-globin gene 3' enhancer contains multiple binding sites for an erythroid-specific protein. Genes Dev 1988, 2:1089-1100.
34. Moroni E., Mastrangelo T., Razzini R., et al. Regulation of mouse p45 NF-E2 transcription by an erythroid-specific GATA-dependant intronic alternative promoter. J Biol Chem 2000, 275:10567-10576.
35. Socolovsky M., Nam H., Fleming M.D., Haase V.H., Brugnara C., Lodish H.F. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 2001, 98:3261-3273.
36. Ebert B.L., Bunn H.F. Regulation of the erythropoietin gene. Blood 1999, 94:1864-1877.
37. Rylski M., Welch J.J., Chen Y.-Y., et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 2003, 23:5031-5042.
38. Socolovsky M. Molecular insights into stress erythropoiesis. Curr Opin Hematol 2007, 14:215-224.
39. Anguita E., Hughes J., Heyworth C., Blobel G.A., Wood W.G., Higgs D.R. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 2004, 23:2841-2852.
40. Grass J.A., Boyer M.E., Pal S., Wu J., Weiss M.J., Bresnick E.H. GATA-1-dependant transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A 2003, 100:8811-8816.
41. Munugalavadla V., Dore L.C., Tan B.L., et al. Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation. Mol Cell Biol 2005, 25:6747-6759.
42. Papetti M., Wontakal S.N., Stopka T., Skoultchi A.I. GATA-1 directly regulated p21 gene expression during erythroid differentiation. Cell Cycle 2010, 9:1972-1980.